CLINICAL_TRIALS
trial_result
· 2021-05-14
Clinical Trial Update: Tanezumab In Osteoarthritis Of The Hip Or Knee [Phase 3]
Summary
Phase 3 clinical trial update for tanezumab in osteoarthritis of the hip or knee has been terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 3 | Status: TERMINATED | Results posted: 2021-05-14